---
aliases: /news/cardinal-health-announces-pharmaceutical-segment-organizational-changes
archetype: press-release
author:
  - Radhika Narayanan
basePath: /news/
breadcrumbLinks:
  - /
  - /news/
  - ''
breadcrumbs:
  - Home
  - News
  - Cardinal Health Announces Pharmaceutical Segment Organizational Changes
categories:
  - 'Medigy: Media (Press) Release'
  - 'Healthcare IT Today: C-Suite & Leadership'
  - >-
    Frost & Sullivan: Pharmaceuticals, Biotechnology & Drug Discovery
    Technologies
categorySlug:
  - 'medigy: media (press) release'
  - 'healthcare it today: c-suite & leadership'
  - >-
    frost & sullivan: pharmaceuticals, biotechnology & drug discovery
    technologies
categoryUrl:
  - topic/medigy-media-press-release
  - topic/healthcare-it-today-c-suite-leadership
  - >-
    topic/frost-sullivan-pharmaceuticals-biotechnology-drug-discovery-technologies
categoryLabel:
  - Media (Press) Release
  - C-Suite & Leadership
  - 'Pharmaceuticals, Biotechnology & Drug Discovery Technologies'
contentCategories: netspective-medigy-news-curated-content
institution:
  - id: 2657
    title: 'Cardinal Health, Inc.'
    description: >-
      We are a team of approximately 44,000 mission-driven partners striving
      each day to advance healthcare and improve lives. We are Essential to
      care™. We are a crucial link between the clinical and operational sides of
      healthcare, delivering end-to-end solutions and data-driving insights that
      advance healthcare and improve lives every day. With deep partnerships,
      diverse perspectives and innovative digital solutions, we build
      connections across the continuum of care. 


      Care is everywhere, and so is Cardinal Health. Our healthcare solutions
      across the continuum of care help providers and healthcare systems improve
      patient outcomes. We offer industry expertise and an expanding portfolio
      of safe, effective products that improve quality, manage costs and reduce
      complexity. With our trusted regulatory experience, insights, and
      infrastructure, we help manufacture and source products that meet the
      demand for value-driven, comprehensive healthcare solutions.
    alias: /profile /offeror/institution/cardinal-health-inc
    slug: cardinal-health-inc
    url: /profile/offeror/institution/cardinal-health-inc
    logo: 2657-logo.JPEG
offering: null
layOut: news-press-release-single
date: '2022-09-26'
description: ' --Victor Crawford will step down as CEO of Pharmaceutical Segment-- --Debbie Weitzman, President of Pharmaceutical Distribution, named CEO of Pharmaceutical Segment-- ,  /PRNewswire/ -- Cardinal Heal'
favIconImage: null
featuredImage:
  alt: Cardinal Health Announces Pharmaceutical Segment Organizational Changes
  format: JPEG
  href: d1989757-d328-5545-a341-513dd0aedc6a-featuredImage.jpeg
  size:
    - 843
    - 1608
  valid: true
  workPackage: 15060
  wpAttachment:
    fileName: Curated_Featured_Image.jpg
    link: /api/v3/attachments/27631/content
featuredPdf: null
htmlMetaData:
  author: null
  description: null
  generator: null
  viewport: null
  articlemodified_time: null
  articlepublished_time: null
  msvalidate.01: null
  ogdescription: null
  ogimage: null
  ogsite_name: null
  ogtitle: null
  ogtype: null
  ogupdated_time: null
  ogurl: null
  yandex-verification: null
  robots: null
  fbapp_id: null
  oglocale: null
  fbadmins: null
  articlepublisher: null
  google-site-verification: null
  keywords: null
id: 15060
identifier: News
lastMod: '2022-09-26T09:24:28.064542Z'
link:
  brand: newsroom.cardinalhealth.com
  href: >-
    https://newsroom.cardinalhealth.com/2022-09-08-Cardinal-Health-Announces-Pharmaceutical-Segment-Organizational-Changes
  original: >-
    https://newsroom.cardinalhealth.com/2022-09-08-Cardinal-Health-Announces-Pharmaceutical-Segment-Organizational-Changes
href: >-
  https://newsroom.cardinalhealth.com/2022-09-08-Cardinal-Health-Announces-Pharmaceutical-Segment-Organizational-Changes
original: >-
  https://newsroom.cardinalhealth.com/2022-09-08-Cardinal-Health-Announces-Pharmaceutical-Segment-Organizational-Changes
mastHead: NEWS
mdName: d1989757-d328-5545-a341-513dd0aedc6a.md
openGraphMetaData:
  ogdescription: null
  ogtitle: null
  ogurl: null
  ogimage: null
  ogsite_name: null
  ogtype: null
  ogupdated_time: null
  ogimageheight: null
openProjectCustomFields:
  cleanUrl: >-
    https://newsroom.cardinalhealth.com/2022-09-08-Cardinal-Health-Announces-Pharmaceutical-Segment-Organizational-Changes
  medigyTopics:
    - 'Medigy: Media (Press) Release'
    - 'Healthcare IT Today: C-Suite & Leadership'
    - >-
      Frost & Sullivan: Pharmaceuticals, Biotechnology & Drug Discovery
      Technologies
  sourceUrl: >-
    https://newsroom.cardinalhealth.com/2022-09-08-Cardinal-Health-Announces-Pharmaceutical-Segment-Organizational-Changes
openProjectWorkPackageType: Press Release
searchCategory: News
slug: >-
  newsroom-cardinal-health-announces-pharmaceutical-segment-organizational-changes
source: open-project-curations
status: ''
sub: brief
tags:
  - News
title: Cardinal Health Announces Pharmaceutical Segment Organizational Changes
via: ' '
insights_description: null
insights_name: null
viaLink: null
relatedOfferings:
  - label: Insilico Medicine's Pharma.AI
    permalink: /offering/insilico-medicines-pharma-ai
    categories:
      - 'Healthcare IT News: Artificial Intelligence'
      - 'Symplur: Pharma'
      - >-
        Frost & Sullivan: Pharmaceuticals, Biotechnology & Drug Discovery
        Technologies
    offeringId: 13431
  - label: Ergomed Clinical Monitoring
    permalink: /offering/ergomed-clinical-monitoring
    categories:
      - 'KLAS: Clinical Surveillance'
      - >-
        Frost & Sullivan: Pharmaceuticals, Biotechnology & Drug Discovery
        Technologies
    offeringId: 13032
twitterMetaData:
  twittercard: null
  twitterdescription: null
  twittertitle: null
  twitterimage: null
  twitterurl: null
---
<div id="readability-page-1" class="page"><div wd_resize="formatNews" wd_print_url="https://newsroom.cardinalhealth.com/2022-09-08-Cardinal-Health-Announces-Pharmaceutical-Segment-Organizational-Changes?printable=1"> <p>--<span>Victor Crawford</span> will step down as CEO of Pharmaceutical Segment--</p> <p>--<span>Debbie Weitzman</span>, President of Pharmaceutical Distribution, named CEO of Pharmaceutical Segment--</p> <p>,  /<a href="http://www.prnewswire.com/" target="_blank">PRNewswire</a>/ -- Cardinal Health (NYSE: CAH) today announced <span>Debbie Weitzman</span>, current President of Pharmaceutical Distribution, will become CEO of the Company's Pharmaceutical Segment. Weitzman will replace <span>Victor Crawford</span>, who will be stepping down as Pharmaceutical Segment CEO effective <span>September 19</span>, but will remain with the company until <span>November 13</span> to help with the transition. The role of President of Pharmaceutical Distribution will be eliminated.</p>      <p>                         <a href="https://mma.prnewswire.com/media/640263/Cardinal_Health_Logo.html" target="_blank" rel="nofollow">                                              </a>                 </p> <p>The company has further streamlined the Pharmaceutical Segment by restructuring and eliminating additional roles. As a result of these changes, the Pharmaceutical and Specialty Distribution businesses will both report directly to <span>Debbie Weitzman</span>.</p> <p>"Debbie has been a tremendous leader at Cardinal Health, and we believe her knowledge and experience make her the right person to lead our redesigned Pharmaceutical Segment," said <span>Jason Hollar</span>, Chief Executive Officer of Cardinal Health. "I believe this new design will allow us to have added focus on specialty distribution, which is a key growth area for the company, as well as simplify how our customers and manufacturers work with us."</p> <p>Hollar added, "On behalf of the Board and entire company, I want to thank Victor for his leadership and many contributions to our business and culture during his time with Cardinal Health. Victor's steadfast leadership helped our Pharmaceutical Segment navigate the challenging environment during the pandemic, and we're grateful he will remain with us through <span>November 13</span> to ensure a smooth transition."</p> <p>The moves in the Pharmaceutical Segment come as part of the company's broader simplification efforts to streamline its organizational structure and are specifically aimed to strengthen the company's Pharmaceutical and Specialty Distribution, as well as bring together similar services under one team.</p> <p><b>About <span>Debbie Weitzman</span></b></p><p><span>Debbie Weitzman</span> has been President of Pharmaceutical Distribution at Cardinal Health since 2017, leading the company's distribution efforts to thousands of pharmacies across the care continuum, from retail and hospital pharmacies to long-term care and community health center pharmacies.&nbsp;Debbie also led the launch of and oversees Outcomes™, a unified ecosystem that brings together patient engagement, clinical intervention and pharmacy workflow solutions to enhance patient outcomes.</p> <p>Throughout her 16-year career at Cardinal Health, Debbie has served in varying leadership roles across sales and distribution operations. Debbie has extensive international experience having previously served as the senior vice president and general manager of Cardinal Health Puerto Rico<b><i>,</i></b>&nbsp;responsible for sales and distribution operations for pharmaceutical products, medical-surgical products, hospital pharmacy management and logistics services in <span>Puerto Rico</span> and <span>Latin America</span>.</p> <p>Prior to joining Cardinal Health, Debbie held positions of increasing responsibility at Johnson &amp; Johnson Medical Caribbean. She began her career in banking at J.P. Morgan, followed by various marketing roles in consumer brand management both in <span>the United States</span> and <span>Puerto Rico</span>.</p> <p>Debbie serves on the Board of Directors for the National Association of Chain Drug Stores, and is a delegate with the National Association of Wholesalers. She earned her bachelor's degree in history from <span>Dartmouth College</span> and a master's degree from Kellogg Graduate School of Management at <span>Northwestern University</span>.</p> <p><b>About Cardinal Health </b></p><p>Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for health care facilities. With 50 years in business, operations in more than 30 countries and approximately 44,000 employees globally, Cardinal Health is essential to care. Information about Cardinal Health is available at cardinalhealth.com.</p> <p><b>Contacts<br></b>Media: <span>Erich Timmerman</span>, <a href="mailto:erich.timmerman@cardinalhealth.com" target="_blank" rel="nofollow">erich.timmerman@cardinalhealth.com</a>&nbsp;and 614.757.8231<br>Investors: <span>Kevin Moran</span>, <a href="mailto:kevin.moran@cardinalhealth.com" target="_blank" rel="nofollow">kevin.moran@cardinalhealth.com</a>&nbsp;and 614.757.7942</p>    <p>SOURCE  Cardinal Health</p> <p></p></div></div>